Türkvatan Aysel, Akdur Pinar Ozdemir, Altinel Mert, Olçer Tülay, Turhan Nesrin, Cumhur Turhan, Akinci Serkan, Ozkul Fatih
Department of Radiology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey.
Diagn Interv Radiol. 2009 Mar;15(1):22-30.
To evaluate the diagnostic accuracy of multidetector computed tomography (MDCT) for preoperative staging of renal cell carcinoma (RCC) using the 1997 TNM (tumor, node, metastasis) classification.
We conducted a retrospective review of MDCT in 57 consecutive patients with RCC performed for tumor staging before radical (n = 51) or partial nephrectomy (n = 6). The scanning protocol of MDCT consisted of unenhanced and biphasic contrast-enhanced scans during corticomedullary and nephrographic phases. MDCT and surgical-histopathologic staging were performed using the 1997 TNM staging system. The results of MDCT were compared with the histopathological results. Agreement between the two staging methods was evaluated using the kappa (kappa) statistic.
Consistency between MDCT and histopathologic staging was excellent for T staging (kappa= 0.87), fair for N staging (kappa= 0.40), and excellent for M staging (kappa= 1.00). Fifty-one of 57 tumors were correctly staged, five overstaged and one understaged by MDCT, with an overall accuracy of 89%. MDCT was able to correctly identify and localize the extension of the tumor thrombus in all 10 patients. In the evaluation of nodal involvement, 42 of 57 patients (74%) were correctly staged, 11 (19%) overstaged, and four (7%) understaged.
MDCT with a dynamic contrast enhancement protocol is an accurate method for preoperative staging of RCC. MDCT with multiplanar reconstruction capability enables a reliable detection and characterization of the tumor, but the involvement of lymph nodes by tumor is still difficult to predict because it is based on node size criterion only.
使用1997年TNM(肿瘤、淋巴结、转移)分类法评估多排螺旋计算机断层扫描(MDCT)对肾细胞癌(RCC)术前分期的诊断准确性。
我们对57例连续的RCC患者进行了MDCT回顾性研究,这些患者在根治性肾切除术(n = 51)或部分肾切除术(n = 6)前进行了肿瘤分期。MDCT扫描方案包括皮质髓质期和肾实质期的平扫及双期增强扫描。MDCT和手术病理分期均采用1997年TNM分期系统。将MDCT结果与组织病理学结果进行比较。使用kappa(κ)统计量评估两种分期方法之间的一致性。
MDCT与组织病理分期在T分期方面一致性极佳(κ = 0.87),N分期方面一般(κ = 0.40),M分期方面一致性极佳(κ = 1.00)。57个肿瘤中有51个分期正确,5个被MDCT高估,1个被低估,总体准确率为89%。MDCT能够在所有10例患者中正确识别并定位肿瘤血栓的延伸。在评估淋巴结受累情况时,57例患者中有42例(74%)分期正确,11例(19%)被高估,4例(7%)被低估。
采用动态对比增强方案的MDCT是RCC术前分期的准确方法。具有多平面重建功能的MDCT能够可靠地检测和鉴别肿瘤,但仅基于淋巴结大小标准仍难以预测肿瘤是否累及淋巴结。